RESEARCH SUPPORT 2009 – Present (Ordered by value).

[1] MRC Strategic Grant: Population and Systems Medicine Board
“Persistent Fatigue Induced by Interferon-alpha: A New Immunological Model for Chronic Fatigue Syndrome”.
Start date: 1/3/12, Duration: 36 months, Value: £3.7m
Grant holders: Carmine M. Pariante (PI), Trudie Chalder, Richard Dobson, Matthew Hotopf, Anthony Cleare, Valeria Mondelli

[2] Biomedical Research Centre for Mental Health – EPI Cluster – Bioinformatics and Statistics
NIHR – National Institute For Health Research
Start date: 2012 – 2017, Duration: 60 months, Value: £1,456,812
Grant Holders: Richard Dobson (PI)

[3] Guys & SLaM Charity Capital Award
Start date: 2014, Value £1.2m
Grant Holder: Richard Dobson (PI)

[4] EU Innovative Medicines Initiative (IMI)
“European Medical Information Framework (EMIF)”
Start Date 7/12, Duration: 2012-2017, Value: £1.2m
Grant Holders: Andy Simmons, Simon Lovestone (PI), Richard Dobson, Angela Hodges

[5] Platform development for IMI2 RADAR-CNS, IMI2 Start date: 2015, Duration: 60 months, Value: €1.2m Grant Holders: Richard Dobson (PI), Amos Folarin

[6] NIHR BRU-D Capital Award
Start date: 2012-2017, Duration: 60 months, Value: £900k for High Performance Computing expansion)

[7] MRC Neurosciences and Mental Health
“Low coverage sequencing for the detection and analysis of genomic structural variants in schizophrenia”.
Start date: 1/10/11, Duration: 36 months, Value: £1m
Grant holders: John Powell (PI), Richard Dobson, Elvira Bramon, Robin Murray

[8] Alzheimer’s Research Trust (ART) major award reference PG-10-003
“Combinatorial biomarkers for dementia prodromes, prediction, pathology and progression”
Start date: 1/9/2010, Duration: 60 months, Value: £775k
Grant Holders: Prof Simon Lovestone (PI), Dr Malcolm Ward, Dr Andrew Weston, Prof Richard Brown, Dr Richard Dobson, Dr Angela Hodges, Prof Graham Lord, Dr Andy Simmons

[9] MRC Research Project
“Gene regulatory variation in the developing human brain and its role in neuropsychiatric disorders”
Grant Holders: Nick Bray (PI), Richard Dobson, Cathryn Lewis, Leo Schalkwyk.
Start Date 3/03/14, Duration: 36 months, Value: £497,359

[10] EU H2020 Big data and Open Data Innovation and take-up
“Khresmoi Multilingual Medical Text Analysis, Search and Machine Translation Connected
in a Thriving Data-Value Chain (KConnect)”
Grant Holders: Richard Dobson (Joint PI), Rob Stewart
Start Date 1/01/15, Duration: 30 months, Value: £300k

[11] Lilly Research Awards Programme (LRAP)
“An integrated systems view of Alzheimer’s disease in patients harboring rare risk variants in TREM2”
Start Date: 1/10/14, Duration: 24 months: Value: £265k
R Dobson (PI), S Newhouse, A Hodges, S Kiddle

[12] MRC Fellowship
“Early identification of Alzheimer’s Disease: dynamic biomarkers for enrichment of clinical trials”
Start date: 1/04/14, Duration: 3 years 31/03/17, Value: £253,519
Kiddle, S. (PI), Dobson, R., Mill, J.

[13] Medical Research Council: Grant Ref: MC_PC_14089
“UK Infrastructure for Large-scale Clinical Genomics Research”
Start Date: 1/10/14, Duration: 18 months, Value: £251k
Grant Holders: Amos Folarin, Stephen Newhouse, Richard Dobson

[14] EC – European Commission
“DESIRE – Development and Epilepsy – Strategies for Innovative Research to improve diagnosis, prevention and treatment in children with difficult to treat Epilepsy”
Start date: 1/10/13, Duration: 60 months Value: £244,517
Grant Holders: D Pal (PI), R Dobson

[15] Alzheimer’s Society Fellowship
“Understanding how genomic, transcriptomic and proteomic variation is associated with metabolic changes in Alzheimer’s Disease”
Start date: 1/9/12, Duration: 36 months, Value: £200k
Grant holders: Petra Proitsi (PI), Richard Dobson, John Powell

[16] MNDA
“Development of a high throughput gene, environment and epigenetics database and analysis system for international ALS research”
Start date: 1/10/14, Duration: 24 months, Value: £195k
Grant Holders: Richard Dobson (Joint PI), Ammar al Chalabi

[17] MRC
“Immuno-psychiatry: a consortium to test the opportunity for immunotherapeutics in psychiatry”
Start date: 1/05/14, Duration: 24 months, Value £174k
Pariante, C. (PI), Cattaneo, A., Dobson, R., Newhouse, S., Stewart, R., Zunszain, P.

[18] Janssen Pharmaceuticals PhD Studentship
“Identification of novel biomarkers for disease progression in Alzheimer’s disease”
Start Date: 2013, Duration: 48 months, Value: £131k
Grant holders: Richard Dobson (joint PI), Simon Lovestone.

[19] Joint Clinical and Translational Science Initiative (CTSI) at the University of California San Francisco & NIHR BRC-MH
“NIHR Biomedical Research Centre Infrastructure Award for USCF-KHP Data sharing programme”.
Start date: 13/2/12, Duration: 12 months, Value: £120k
Grant holders: Richard Dobson (Joint PI), Andy Simmons (Joint PI), Simon Lovestone

[20] GE
“Identify blood based biomarkers for PET Amyloid change in MCI”
Start date: TBC:, Duration: 12 months, Value: £130k
Richard Dobson (PI), Abdul Hye –>

[21] KHP Challenge Fund
“Preventing relapse using remote monitoring of sleep disturbance in schizophrenia.”
Start date: 1/2/15, Duration: 12 months, Value: £100k
Grant Holders: James MacCabe (PI), Richard Dobson, Nick Meyer, Amos Folarin, Philip McGuire

[22] BBSRC Case Studentship with Illumina Inc
“Systems-biology based approaches for the identification of genes controlling complex phenotypic traits”
Start Date: 2013, Duration: 48 months, Value: £90k
Grant Holders: Richard Dobson (PI), Cathryn Lewis

[23] Alzheimer’s Society PhD Studentship
“Creating an early diagnostic blood test for Alzheimer’s”
Start date: 2013, Duration: 36 months, Value: £80k
Grant Holders: Richard Dobson (PI), Steven Kiddle

[24] Joint NIHR Biomedical Research Centre Strategic Project Award
“Genetic Causes of Neurodevelopmental Delay in Children: Translation and interpretation of novel pathogenic copy number variants and novel rare exonic mutations into clinical genetic practice”
Start date: 1/1/10, Duration: 12 months, Value: £75k
Grant holders: Dr Sarah Curran (PI), Richard Dobson, Deb Pal, Patrick Bolton, Paul Gringras, Caroline Ogilvie, David Collier, Simon Holden

[25] KBI Studentship
“Integrated approaches to risk prediction in first-episode psychosis”
Start date: 1/10/14, Duration: 36 months, Value: £75k
Grant Holders: Richard Dobson (PI), Robin Muray, Stephen Newhouse

[26] Rosetrees Trust
“A blood test for Alzheimer’s disease (Computational approaches to identify Alzheimer’s disease progression biomarkers and evaluate their performance)”
Start date: 1/1/11, Duration: 24 months, Value: £49.5k
Grant Holders: Angela Hodges, Simon Lovestone (PI), Richard Dobson

[27] Kings Health Partners
“EPI-INFO: Developing an epilepsy patient database at King’s Health Partners for audit, service commissioning & development, and research”.
Start date: Q3 2012, Duration: 12 months, Value: £50k
Grant holders: Mark Richardson (PI), Richard Dobson, Deb Pal, Matthew Broadbent

[28] BRC EPI/Nucleus award
“Investigating Adverse Effects of Psychiatric Drugs through Data-Mining of Electronic Health Records and Integration of Clinical and Genomic Data”
Start date: Q3 2013, Duration: 12 months, Value: £50k
Grant holders: Richard Dobson (PI), Rob Stewart, Caroline Johnston

[29] BRC EMCT Theme
“Genome-wide expression change over the course of exposure-based psychological therapy”
Start date: 1/1/2014, Duration: 3 months, Value: £24k
Grant Holders: Prof Thalia Eley (PI), Dr Richard Dobson, Dr Gerome Breen, Dr Chloe Wong, Dr Kathryn Lester

Leave a Reply